Clinical Trials Browser

Phase 2/3 × Mouth Neoplasms × Cyclophosphamide × Clear all

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

Phase 2/3 Terminated

Mouth Neoplasms